Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

Gut
Francis MegraudStudy Group participants

Abstract

Resistance to antibiotics is the major cause of treatment failure of Helicobacter pylori infection. A study was conducted to assess prospectively the antibacterial resistance rates of H pylori in Europe and to study the link between outpatient antibiotic use and resistance levels in different countries. Primary antibiotic resistance rates of H pylori were determined from April 2008 to June 2009 in 18 European countries. Data on yearly and cumulative use over several years of systemic antibacterial agents in ambulatory care for the period 2001-8 were expressed in Defined Daily Doses (DDD) per 1000 inhabitants per day. The fit of models and the degree of ecological association between antibiotic use and resistance data were assessed using generalised linear mixed models. Of 2204 patients included, H pylori resistance rates for adults were 17.5% for clarithromycin, 14.1% for levofloxacin and 34.9% for metronidazole, and were significantly higher for clarithromycin and levofloxacin in Western/Central and Southern Europe (>20%) than in Northern European countries (<10%). Model fit improved for each additional year of antibiotic use accumulated, but the best fit was obtained for 2005. A significant association was found between outpa...Continue Reading

Citations

Feb 14, 2013·JAMA : the Journal of the American Medical Association·Douglas R MorganLaurence H Baker
Sep 10, 2013·Journal of Visceral Surgery·C MoulyJ-M Regimbeau
Mar 29, 2013·Clinical and Translational Gastroenterology·Javier P Gisbert, Xavier Calvet
Mar 7, 2013·The Journal of Antimicrobial Chemotherapy·Nicole WueppenhorstErik-Oliver Glocker
Dec 24, 2013·World Journal of Gastroenterology : WJG·Enzo IerardiMariabeatrice Principi
May 17, 2014·World Journal of Gastroenterology : WJG·Giovanni CammarotaAntonio Gasbarrini
May 17, 2014·World Journal of Gastroenterology : WJG·Chang Seok Bang, Gwang Ho Baik
May 17, 2014·World Journal of Gastroenterology : WJG·Jyh-Chin YangChun-Jung Lin
May 6, 2014·Journal of Pediatric Gastroenterology and Nutrition·Hamza KarabiberAli Ozer
Oct 16, 2013·Digestive Diseases and Sciences·J P GisbertUNKNOWN H. pylori Study Group of the Spanish Gastroenterology Association
Dec 29, 2013·Applied Microbiology and Biotechnology·Le GuoYingying Xing
Mar 5, 2014·The American Journal of Gastroenterology·M Constanza CamargoCharles S Rabkin
Sep 16, 2014·Journal of Pediatric Gastroenterology and Nutrition·Midori MituiJason Y Park
Mar 26, 2014·Internal and Emergency Medicine·Giovanni CammarotaAntonio Gasbarrini
May 23, 2013·European Journal of Clinical Pharmacology·Hassan SeddikAhmed Benkirane
Mar 6, 2015·Jundishapur Journal of Microbiology·Omid Tadjrobehkar, Hamid Abdollahi
Mar 7, 2014·Digestive Diseases and Sciences·M CampanaleA Gasbarrini
Nov 2, 2013·Internal and Emergency Medicine·Maria Pina DoreDavid Yates Graham
Oct 1, 2014·Current Opinion in Gastroenterology·Peter Malfertheiner, Michael Selgrad
Jul 6, 2014·The Journal of Antimicrobial Chemotherapy·Nicole WüppenhorstUNKNOWN ResiNet Study Group
Sep 18, 2014·European Journal of Gastroenterology & Hepatology·Maider MartosAngel Cosme
Oct 9, 2013·Current Opinion in Gastroenterology·Peter MalfertheinerMichael Selgrad
Jun 25, 2014·Scandinavian Journal of Gastroenterology·Jung Won LeeHyun Chae Jung
Oct 6, 2015·Scandinavian Journal of Gastroenterology·Periklis ApostolopoulosGeorgios Alexandrakis
Nov 12, 2015·Scandinavian Journal of Gastroenterology·Mara Di GiulioLuigina Cellini
Sep 25, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Donal M Keogan, Darren M Griffith
Sep 4, 2015·Expert Opinion on Pharmacotherapy·Sotirios D GeorgopoulosStylianos Karatapanis
Jan 22, 2013·Expert Opinion on Pharmacotherapy·Sotirios D GeorgopoulosStylianos Karatapanis
Aug 30, 2013·Expert Review of Gastroenterology & Hepatology·Anthony O'Connor, Colm O'Moráin
Jan 15, 2014·Expert Review of Gastroenterology & Hepatology·Jeng-Yih WuDavid Y Graham
Feb 10, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Sun Gyo LimKee Myung Lee
Feb 7, 2016·Clinics and Research in Hepatology and Gastroenterology·Nelly MullerJean-Charles Delchier
Feb 6, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Zhiqiang SongYan Xue
Feb 3, 2016·The American Journal of Gastroenterology·Jyh-Ming LiouUNKNOWN Taiwan Gastrointestinal Disease and Helicobacter Consortium
Jul 19, 2015·Clinics and Research in Hepatology and Gastroenterology·Hale GokcanIbrahim Koral Onal
Jan 23, 2016·American Journal of Public Health·Kieran C O'DohertyElizabeth S Wilcox
Jun 12, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David Y GrahamMing-Shiang Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.